Academic Urology Unit

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Urology 64%
3. Prostatic Neoplasms 49%
4. Randomized Controlled Trials 41%
5. Guidelines 35%
6. Urinary Incontinence 32%
7. Meta-Analysis 29%
8. Stress Urinary Incontinence 29%
9. Cost-Benefit Analysis 28%
10. Urinary Bladder Neoplasms 27%
11. Transurethral Resection of Prostate 24%
12. Lower Urinary Tract Symptoms 22%
13. Suburethral Slings 21%
14. Therapeutics 20%
15. Practice Guidelines 20%
16. Quality of Life 18%
17. Renal Cell Carcinoma 17%
18. Lithotripsy 16%
19. Prostate 16%
20. Pelvic Floor 15%
21. Confidence Intervals 14%
22. Costs and Cost Analysis 13%
23. Urinary Bladder 13%
24. Patient Reported Outcome Measures 12%
25. Urinary Tract Infections 11%
26. Ureteroscopy 11%
27. Odds Ratio 10%
28. Catheterization 10%
29. Delivery of Health Care 10%
30. Urinary Catheters 10%
31. MEDLINE 10%
32. Urodynamics 9%
33. Prostatectomy 9%
34. Muscles 9%
35. Catheters 9%
36. Economics 9%
37. Consensus 9%
38. Cystectomy 9%
39. Kidney Neoplasms 9%
40. Quality-Adjusted Life Years 8%
41. Urologic Neoplasms 8%
42. Recurrence 8%
43. Tamsulosin 8%
44. Prostatic Hyperplasia 8%
45. Congresses 8%
46. Lymph Node Excision 8%
47. Prospective Studies 7%
48. Neoplasms 7%
49. Urinary Diversion 7%
50. Biopsy 7%
51. Patient Participation 7%
52. Sexual Health 7%
53. Placebos 7%
54. Nephrectomy 7%
55. Watchful Waiting 7%
56. Uncertainty 7%
57. Conservative Treatment 7%
58. Antibiotic Prophylaxis 6%
59. Priapism 6%
60. Urethral Stricture 6%
61. Kidney 6%
62. Overactive Urinary Bladder 6%
63. Health 6%
64. Indwelling Catheters 6%
65. Urinary Bladder Neck Obstruction 6%
66. Percutaneous Nephrolithotomy 6%
67. Equivalence Trials 6%
68. Guideline Adherence 6%
69. Equipment and Supplies 5%
70. Education 5%
71. Electric Stimulation 5%
72. Social Media 5%
73. Prostate-Specific Antigen 5%
74. Chronic Kidney Failure 5%
75. Random Allocation 5%
76. Urinary Retention 5%
77. Big Data 5%
78. Network Meta-Analysis 5%
79. Ureter 5%
80. Databases 5%
81. Health Care Outcome Assessment 5%
82. Nifedipine 5%
83. Decision Making 5%
84. Intermittent Urethral Catheterization 5%